Angiotensin II Receptor Antagonists Against Migraine in Pregnancy: Fatal Outcome

Overview

Journal J Headache Pain

Publisher Biomed Central

Date 2010 Jan 12

PMID 20063032

Citations 6

Authors

Kirsti Haaland

Affiliations

Soon will be listed here.

Abstract

A pregnant young woman with a severe migraine is prescribed candesartan, an angiotensin II type 1 receptor antagonist (AT II antagonists). This has a positive effect-except for severe maldevelopment of her fetus. There is an increase in the use of the fetotoxic drugs, AT II antagonists and angiotensin-converting enzyme inhibitors, as prophylactic treatment of migraines, in addition to their use as hypertensives.

Citing Articles

Exposure to medication for neurological disease in pregnancy - time to consider the long-term implications?.

Liu C, Pace S, Bromley R, Dobson R EClinicalMedicine. 2023; 63:102157.

PMID: 37662523 PMC: 10474373. DOI: 10.1016/j.eclinm.2023.102157.

Candesartan Does Not Activate PPARγ and Its Target Genes in Early Gestation Trophoblasts.

Neuper L, Kummer D, Forstner D, Guettler J, Ghaffari-Tabrizi-Wizsy N, Fischer C Int J Mol Sci. 2022; 23(20).

PMID: 36293183 PMC: 9603971. DOI: 10.3390/ijms232012326.

Evaluation of Antioxidant Therapeutic Value of ACE Inhibitor as Adjunct Therapy on Type 2 Diabetes Mellitus Patients with Cardiovascular Disease.

Elfowiris A, Banigesh A ACS Pharmacol Transl Sci. 2022; 5(6):413-418.

PMID: 35711816 PMC: 9194932. DOI: 10.1021/acsptsci.1c00269.

Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.

Shimada C, Akaishi R, Cho K, Morikawa M, Kaneshi Y, Yamda T Hypertens Res. 2015; 38(5):308-13.

PMID: 25693853 DOI: 10.1038/hr.2015.12.

Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.

Oppermann M, Padberg S, Kayser A, Weber-Schoendorfer C, Schaefer C Br J Clin Pharmacol. 2012; 75(3):822-30.

PMID: 22816796 PMC: 3575949. DOI: 10.1111/j.1365-2125.2012.04388.x.

References

Evers S, Afra J, Frese A, Goadsby P, Linde M, May A . EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol. 2006; 13(6):560-72. DOI: 10.1111/j.1468-1331.2006.01411.x. View

Tronvik E, Stovner L, Helde G, Sand T, Bovim G . Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2002; 289(1):65-9. DOI: 10.1001/jama.289.1.65. View

Etminan M, Levine M, Tomlinson G, Rochon P . Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis. Am J Med. 2002; 112(8):642-6. DOI: 10.1016/s0002-9343(02)01100-2. View

Bender W . ACE inhibitors for prophylaxis of migraine headaches. Headache. 1995; 35(8):470-1. DOI: 10.1111/j.1526-4610.1995.hed3508470.x. View

Serreau R, Luton D, Macher M, Delezoide A, Garel C, Jacqz-Aigrain E . Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG. 2005; 112(6):710-2. DOI: 10.1111/j.1471-0528.2004.00525.x. View

Owada K . Efficacy of candesartan in the treatment of migraine in hypertensive patients. Hypertens Res. 2004; 27(6):441-6. DOI: 10.1291/hypres.27.441. View

Schrader H, Stovner L, Helde G, Sand T, Bovim G . Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ. 2001; 322(7277):19-22. PMC: 26600. DOI: 10.1136/bmj.322.7277.19. View

Sanchez S, Seltzer A, Fuentes L, Forneris M, Ciuffo G . Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. Eur J Pharmacol. 2008; 588(1):114-23. DOI: 10.1016/j.ejphar.2008.04.014. View

Modi S, Lowder D . Medications for migraine prophylaxis. Am Fam Physician. 2006; 73(1):72-8. View

10.

Ramadan N . Current trends in migraine prophylaxis. Headache. 2007; 47 Suppl 1:S52-7. DOI: 10.1111/j.1526-4610.2007.00677.x. View

11.

Stark R, Stark C . Migraine prophylaxis. Med J Aust. 2008; 189(5):283-8. DOI: 10.5694/j.1326-5377.2008.tb02028.x. View

12.

Guron G, Sundelin B, Wickman A, Friberg P . Angiotensin-converting enzyme inhibition in piglets induces persistent renal abnormalities. Clin Exp Pharmacol Physiol. 1998; 25(2):88-91. DOI: 10.1111/j.1440-1681.1998.tb02182.x. View

13.

Kato K, Okuda M, Ishikawa H, Takahashi T, Hirahara F . Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected. J Obstet Gynaecol Res. 2008; 34(2):242-6. DOI: 10.1111/j.1447-0756.2008.00762.x. View

14.

Lacoste M, Cai Y, Guicharnaud L, Mounier F, Dumez Y, Bouvier R . Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: Role of the Renin-Angiotensin system. J Am Soc Nephrol. 2006; 17(8):2253-63. DOI: 10.1681/ASN.2005121303. View

15.

Silberstein S . Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55(6):754-62. DOI: 10.1212/wnl.55.6.754. View